Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ASCO Annual Meeting 2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

2024 ASCO Annual Meeting

Keep up to date with all the top stories and latest evidence with our hub page, including official congress videos and expert takeaways.
ADVANCED SEARCH
Log in
Top
Reactions Weekly
Published in: Reactions Weekly 1/2022

01-03-2022 | Immunodeficiency | Case report

Folinic-acid

Lack of efficacy : case report

Published in: Reactions Weekly | Issue 1/2022

Login to get access

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
…
Literature
Kan M, et al. PERSISTENT MTHFD1-DEFICIENT SEVERE COMBINED IMMUNODEFICIENCY DESPITE FOLINIC ACID SUPPLEMENTATION; HEMATOPOIETIC ALLOGENEIC TRANSPLANTATION REQUIRED. Annals of Allergy, Asthma and Immunology 127 (Suppl.): S108-S109 abstr. M202, No. 5, Nov 2021. Available from: URL: http://​doi.​org/​10.​1016/​j.​anai.​2021.​08.​343 [abstract]
Metadata
Title
Folinic-acid
Lack of efficacy : case report
Publication date
01-03-2022
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/2022
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-022-12167-z

Other articles of this Issue 1/2022

Reactions Weekly 1/2022 Go to the issue

Case report

Multiple drugs

Case report

Omalizumab

Case report

Adalimumab

Case report

Antineoplastics

Case report

Meningococcal-vaccine-group-b-omv-novartis

Case report

Azathioprine